Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19085442 | 0.90 | MAPK1 (0.32) | MAPK1SELE | |
| SCHEMBL10185805 | 0.82 | LGALS8 (0.33) | — | |
| SCHEMBL13598327 | 0.76 | LGALS3 (0.31) | — | |
| SCHEMBL14270421 | 0.74 | — | — | |
| SCHEMBL16687520 | 0.73 | LGALS3 (0.39) | — | |
| SCHEMBL13827606 | 0.71 | LGALS3 (0.33) | — | |
| SCHEMBL13199410 | 0.71 | OGA (0.33) | — | |
| SCHEMBL13820244 | 0.71 | LGALS3 (0.33) | — | |
| SCHEMBL15468823 | 0.70 | CA2 (0.39) | — | |
| SCHEMBL18805239 | 0.70 | CA2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180028558-A1 | THERAPEUTIC POLYSACCHARIDE MIDI-GAGR AND RELATED MATERIALS AND METHODS | THE UNIVERSITY OF TOLEDO (US) | 2018-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180028558-A1 | THERAPEUTIC POLYSACCHARIDE MIDI-GAGR AND RELATED MATERIALS AND METHODS | ALG1, GLA, ENGASE | MAPK1 3988/4885SELE 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.